Clinical Trials Logo

Filter by:
NCT ID: NCT00094952 Recruiting - Alzheimer's Disease Clinical Trials

Biomarkers and Early Alzheimer's Disease

Start date: April 2003
Phase: N/A
Study type: Observational

The main goal of this project is to use imaging and biomarkers to identify cognitively normal elderly people who are at increased risk for developing mild cognitive impairment (MCI). MCI is the earliest clinically detectable evidence for brain changes due to Alzheimer's disease (AD). The second goal of this project is to describe the inter-relationships among anatomical biomarkers, cerebrospinal fluid biomarkers, and cognition measures in those elderly people who develop MCI.

NCT ID: NCT00108875 Recruiting - Pancreatic Cancer Clinical Trials

Survivin Peptide Vaccination for Patients With Advanced Melanoma, Pancreatic, Colon and Cervical Cancer

Start date: April 2003
Phase: Phase 1/Phase 2
Study type: Interventional

This study evaluates the safety, the immunological response and the clinical outcome of a vaccination with survivin peptides for patients with advanced melanoma, pancreatic, colon and cervical carcinoma.

NCT ID: NCT00149084 Recruiting - Gastritis Clinical Trials

Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. Pylori

Start date: April 2003
Phase: Phase 3
Study type: Interventional

The eradication rate of the standard H. pylori eradication therapy (such as the triple therapy with a proton pump inhibitor [PPI], amoxicillin and clarithromycin) depends on bacterial susceptibility to clarithromycin and genotypes of CYP2C19 in patients. The investigators intend to investigate whether the tailored therapy based on the two above-mentioned factors increases the cure rate of the initial eradication therapy.

NCT ID: NCT00196833 Recruiting - Breast Cancer Clinical Trials

Breast Cancer in Pregnancy Register Study

BCP
Start date: April 2003
Phase:
Study type: Observational

Women who were diagnosed with breast cancer during their pregnancy may be registered in this trial. Data is collected on the foetal outcome 4 weeks after delivery, maternal outcome of pregnancy as well as the breast cancer therapy applied (treatment, response to chemotherapy, type of surgery), diagnostic procedures applied (palpation, US, mammogram) and the outcome of mother and child after 5 years of therapy.

NCT ID: NCT00335205 Recruiting - Clinical trials for Major Depressive Disorder

A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.

Start date: April 2003
Phase: Phase 4
Study type: Interventional

We hypothesize that depressed patients who have not responded to their current antidepressant medication will respond to the addition of ropinirole to their current regimen at a rate better than placebo.

NCT ID: NCT00540774 Recruiting - Mouth Diseases Clinical Trials

Optical Sensor for Photodynamic Detection of Oral Pathology

Start date: April 2003
Phase: N/A
Study type: Interventional

Overall objective of this work is to develop better ways of detecting, diagnosing and measuring oral diseases and structures using light and optical approaches. All different areas of the mouth will be imaged, including healthy, diseased, dysplastic and malignant, as well as oral biofilm, and the imaging data compared against conventional diagnostic approaches such clinical and histopathological and molecular evaluations to (1) gain a better understanding of processes involved in oral pathology and (2) develop a combined patient specific, non-invasive method for the detection, diagnosis and screening of oral pathology and biofilm. Thus our goal is to identify and evaluate microstructural, metabolic, vascular, protein, genomic and metabolomics biomarkers of oral pathology can be used to detect, predict and map oral pathology, especially neoplasia. We are recruiting patients with a wide range of oral conditions including plaque, dry mouth, toothache, root canal treatments, gum disease, oral sores, dysplasia and cancer, autoimmune conditions and others as well as healthy control subjects. We will use a range of non-invasive imaging modalities to obtain information on the ways in which the oral health status affects optical properties, and determine means of detecting and quantifying these factors.. Imaging modalities to be utilized include: 1. Coherence and Doppler Tomography 2. Laser Speckle Imaging 3. Various forms of Spectroscopy 4. Fluorescence

NCT ID: NCT00756769 Recruiting - Clinical trials for Systemic Lupus Erythematosus

Systemic Lupus Erythematosus in Gullah Health

SLEIGH
Start date: April 2003
Phase:
Study type: Observational

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of autoantibodies, multiple organ involvement, and diverse clinical symptoms and immunologic manifestations. African Americans are at a disproportionately higher risk of developing SLE, develop SLE at an earlier age, and have increased morbidity and mortality compared with European Americans. Our central study hypothesis is that there are specific genetic factors that interact with environmental exposures leading to the development of SLE. The African American Gullah population from the Sea Islands of South Carolina and Georgia are unique in their genetic homogeneity with minimal non-African genetic admixture, making them an ideal cohort to address questions of environmental and genetic influence on the development and progression of SLE.

NCT ID: NCT00906802 Recruiting - Pancreatic Cancer Clinical Trials

Benefit of Roux-en-Y (R-Y) Reconstruction After Pancreaticoduodenectomy

Start date: April 2003
Phase: N/A
Study type: Interventional

One of the most common complications of pancreaticoduodenectomy (PD) is delayed gastric emptying (DGE), otherwise known as "gastroparesis," which is not fatal but results in prolonged hospital stay and increased hospital costs. Delayed gastric emptying is defined as nasogastric decompression after postoperative day (POD) 10 or a failure to tolerate a regular diet after POD 14. The incidence of DGE has been reported to range from 5% to 72%.

NCT ID: NCT01171807 Recruiting - Ulcerative Colitis Clinical Trials

Erythrocytes-Mediated Delivery Of Dexamethasone 21-Phosphate In Steroid-Dependent Ulcerative Colitis

Crocodex
Start date: April 2003
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate the efficacy and safety of erythrocyte-mediated delivery of dexamethasone in steroid-dependent ulcerative colitis patients

NCT ID: NCT01219335 Recruiting - Infertility Clinical Trials

Discarded Materials Study

Start date: April 2003
Phase:
Study type: Observational

Use of discarded embryos to advance laboratory expertise and technology in the area of human embryo development and assisted reproductive technologies